Status:
RECRUITING
Characterization of the Melanoma-Specific Immune Response
Lead Sponsor:
University of California, Davis
Conditions:
Melanoma
Eligibility:
All Genders
18-85 years
Brief Summary
The aim of this study is to study T-cells. Blood will be collected and the samples will be used to generate T cell clones. Two separate blood draws will be required at the maximum.
Detailed Description
The aim of the study is to in-vitro characterize and expand T cells specific for melanoma-derived antigens. Peripheral blood with be collected from 20 volunteers with biopsy proven melanoma and 10 age...
Eligibility Criteria
Inclusion
- Biopsy diagnosis of malignant melanoma
- Have had a biopsy diagnosis of malignant melanoma in the past
Exclusion
- Patients taking immunosuppressive medications
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00368615
Start Date
August 1 2007
End Date
August 1 2024
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis Department of Dermatology
Sacramento, California, United States, 95816